Quantitative determination of hippuric and benzoic acids in urine by LC-MS/MS using surrogate standards

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 4, 2010, Pages 534-543

  Penner, Natalia ^a   Ramanathan, Ragu ^a   Zgoda Pols, Joanna ^a   Chowdhury, Swapan ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Benzoic acid; Biomarkers; Hippuric acid; LC MS MS

Indexed keywords

BENZOIC ACID; CARBON 13; EVERNINOMICIN; GENTAMICIN; HIPPURIC ACID; PHENYLALANINE; BENZOIC ACID DERIVATIVE; BIOLOGICAL MARKER; HIPPURIC ACID DERIVATIVE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ASSAY; CALIBRATION; CONTROLLED STUDY; FEMALE; FREEZE THAWING; LIQUID CHROMATOGRAPHY; MOLECULAR STABILITY; MONKEY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; ROOM TEMPERATURE; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; URINALYSIS; ANIMAL; COMPARATIVE STUDY; DRUG SCREENING; MACACA FASCICULARIS; MASS SPECTROMETRY; PROCEDURES; STANDARDS; URINE;

ANIMALS; BENZOIC ACIDS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DRUG EVALUATION, PRECLINICAL; FEMALE; HIPPURATES; MACACA FASCICULARIS; MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; BENZOATES;

EID: 77950367605     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.01.016     Document Type: Article

References (24)

1. Keun H.C. Metabonomic modeling of drug toxicity. Pharmacol. Ther. 2006, 109:92-106.
2. Lindon J.C., Holmes E., Nicholson J.K. Metabonomics techniques and applications to pharmaceutical research & development. Pharm. Res. 2006, 23:1075-1088.
3. Ackermann B.L., Hale J.E., Duffin K.L. The role of mass spectrometry in biomarker discovery and measurement. Curr. Drug Metab. 2006, 7:525-539.
4. Robertson D.G. Current challenges and future developments in metabonomics technology. Metabonomics in Toxicity Assessment 2005, 499-516. CRC Press, Boca Raton, FL. D.G. Robertson, J. Lindon (Eds.).
5. Kochhar S., Jacobs D.M., Ramadan Z., Berruex F., Fuerholz A., Fay L.B. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal. Biochem. 2006, 352:274-281.
6. Kussmann M., Raymond F., Affolter M. OMICS-driven biomarker discovery in nutrition and health. J. Biotechnol. 2006, 124:758-787.
7. Dieterle F., Schlotterbeck G., Ross A., Niederhauser U., Senn H. Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. Chem. Res. Toxicol. 2006, 19:1175-1181.
8. Huang M.Y., Jin C., Liu Y.T., Li B.H., Qu Q.S., Uchida Y., Inoue O., Nakatsuka H., Watanabe T., Ikeda M. Exposure of workers to a mixture of toluene and xylenes. I. Metabolism. Occup. Environ. Med. 1994, 51:42-46.
9. Ramachandran E., Natarajan S. Growth habits of hippuric acid in gel. Cryst. Res. Technol. 2002, 37:1274-1279.
10. Lof A., Wigaeus H.E., Colmsjo A., Lundmark B.O., Norstrom A., Sato N. Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br. J. Ind. Med. 1993, 50:55-59.
11. Saito T., Takeichi S. Simultaneous detection of hippuric acid and methylhippuric acid in urine by Empore disk and gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2002, 30:365-370.
12. Siquera M.E., Paiva M.J.N. Hippuric acid in urine: reference values. Rev. Saúde Pública 2002, 36:723-727. Available from:. http://www.scielosp.org/scielo.php%3Fscript=sci_arttext%26pid=S0034-89102002000700010%26lng=en%26nrm=iso.
13. Phipps A.N., Stewart J., Wright B., Wilson I.D. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between the diet, gut microflora and substrate specificity. Xenobiotica 1998, 28:527-537.
14. Clifford M.N., Copeland E.L., Bloxsidge J.P., Mitchell L.A. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica 2000, 30:317-326.
15. Zuppi C., Messana I., Tapanainen P., Knip M., Vincenzoni F., Giardina B., Nuutinen M. Proton nuclear magnetic resonance spectral profiles of urine from children and adolescences with type 1 diabetes. Clin. Chem. 2002, 48:660-662.
16. LeBel M., Ferron L., Masson M., Pichette J., Carrier C. Benzyl alcohol metabolism and elimination in neonates. Dev. Pharmacol. Ther. 1988, 11:347-356.
17. Arin M.J., Diez M.T., Resines J.A., Alemany M.T. Quantitative estimation of urinary metabolites in ruminants by high-performance liquid chromatography. J. Liq. Chromatogr. 1990, 13:2465-2473.
18. Elgstoen K.B., Zhao J.Y., Anacleto J.F., Jellum E. Potential of capillary electrophoresis, tandem mass spectrometry and coupled capillary electrophoresis-tandem mass spectrometry as diagnostic tools. J. Chromatogr. A 2001, 914:265-275.
19. Langenbeck U., Seegmiller J.E. Gas chromatograph-mass spectrometry studies of hippuric acid derivatives. I. Evaluation of methods for quantitative determination hippuric acid. J. Chromatogr. 1973, 80:81-88.
20. Li W., Cohen L.H. Quantitation of endogenous analytes in biofluid without a true blank matrix. Anal. Chem. 2003, 75:5854-5859.
21. Liang H.R., Takagaki T., Foltz R.L., Bennet P. Quantitative determination of endogenous sorbitol and fructose in human erythrocytes by atmospheric pressure chemical ionization LC tandem mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed Life Sci. 2005, 824:36-44.
22. Penner N.A., Ramanathan R., Chowdhury S., Alton K. Development of a liquid chromatography-mass spectrometry method for quantitative determination of hippuric acid in urine. Proceedings of the 52nd American Society for Mass Spectrometry Meeting 2004.
23. Korfmacher W.A. Bioanalytical assays in drug discovery environment. Using Mass Spectrometry for Drug Metabolism Studies 2005, 1-34. CRC Press LLC, Boca Raton, FL. W.A. Korfmacher (Ed.).
24. Davis J.W., Goodsaid F.M., Bral C.M., Obert L.A., Mandakas G., Garner C.E., Collins N.D., Smith R.J., Rosenblum I.Y. Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol. Appl. Pharmacol. 2004, 200:16-26.